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Summary Dermal fibroblasts cultured from members of a family presenting multiple polyps and sarcomas
were compared with fibroblast strains from unrelated healthy donors for sensitivity to killing by four
genotoxic agents. Cells from the sister of the male proband (strain 3437T), mother (strain 3703T), two of his
paternal aunts (3701T and 3704T) and one paternal uncle (3702T) displayed marked resistance (1.8 to 4.3
times greater than the normal mean) to 4-nitroquinoline 1-oxide (4NQO), a procarcinogen whose DNA-
damaging properties encompass those of both far (254 nm) ultraviolet (UV) light and ionising radiation. These
same 4NQO-resistant cells, however, responded normally to reproductive inactivation by UV light, 'Co
radiation or the alkylating agent methylnitrosourea, signifying that the abnormal resistance of these cells to
4NQO is not associated with aberrant DNA metabolism. In keeping with this conclusion, exposure to a given
dose of 4NQO produced decreased amounts of DNA damage and stimulated lower levels of repair DNA
synthesis in all five 4NQO-resistant strains than in normal controls. Moreover, exogenous radiolabelled 4NQO
accumulated to a lesser extent in the 4NQO-resistant than in the normal fibroblasts. Cell sonicates of strains
3437T, 3701T and 3702T exhibited reduced capacities (40-60% of normal) to catalise the conversion of
4NQO to the proximate carcinogen 4-hydroxyaminoquinoline 1-oxide. However, the 4NQO-resistant strains
3703T and 3704T carried out 4NQO bioreduction at normal rates. Our data therefore indicate that enhanced
resistance to 4NQO cytotoxicity in 3437T, 3701T and 3702T is a consequence of anomalies in both
intracellular accumulation and enzymatic reduction of 4NQO, whereas 4NQO resistance in 3703T and 3704T
appears to result solely from reduced intracellular drug accumulation.
Some two decades ago it was demonstrated that cells from
patients afflicted with xeroderma pigmentosum, an autosomal
recessively transmitted, sunlight-sensitive, skin cancer disease,
exhibit marked intolerance to the cytotoxic effects of ultra-
violet (UV) light ascribable to malfunctional excision-repair
of UV-induced DNA damage (Cleaver, 1968). Since then,
several other cancer-prone conditions characterised by cel-
lular hypersensitivity to physical and chemical carcinogens
and impaired DNA metabolism have been identified (Ram-
say et al., 1982; Paterson & Smith, 1979; Paterson et al.,
1984a,b; Lehmann et al., 1988; Mayne et al., 1988; Cleaver &
Kraemer, 1989; Maher et al., 1990). These findings impli-
cated DNA injury from environmental genotoxins as a key
causative factor in carcinogenesis and led to the notion that
normal enzymatic processing of DNA damage plays a crucial
role in affording protection from the development of the
malignant state (Cleaver, 1989). As a test of this hypothesis,
cells derived from individuals with an assortment of cancer-
associated diseases have been surveyed for their response to a
panel of DNA-damaging agents (see, e.g., Arlett & Harcourt,
1980; Weichselbaum et al., 1980; Paterson et al., 1983;
Deschavanne et al., 1986). The overall aim of this line of
investigation is to obtain new insight into the molecular
mechanisms underlying the interaction between environmen-
tal agents and host susceptibility factors in predisposing
humans to various forms of malignant disease.
We report here the outcome of our studies conducted on
noncancerous dermal fibroblasts established from members
of a family characterised by the presence of excessive colonic
polyps prone to malignant transformation in coexistence with
malignant extra-alimentary sarcomas (Fraumeni et al., 1968).
The pattern of cancer development in the kinship is compati-
ble with autosomal dominant inheritance of a single mutant,
pleiotropic gene of high penetrance (see Figure 1 for an
abridged family pedigree). Strains from five family members
are shown here to exhibit abnormal resistance to killing by
the potent carcinogen 4-nitroquinoline 1-oxide (4NQO), but
to respond normally to 60Co radiation and the alkylating
agent methylnitrosourea (MNU). In addition, 4NQO-resis-
tant strains from two affected family members examined
display normal sensitivity to 254 nm UV light.
4NQO is itself biologically inert until enzymatically con-
verted to an ultimate carcinogenic metabolite. The first step
in 4NQO bioreduction entails the conversion of the parent
compound to 4-hydroxyaminoquinoline 1-oxide (4HAQO)
(Sugimura et al., 1966; Tsuda et al., 1984). Several cellular
reductases are capable of mediating this reaction, including
DT-diaphorase [NAD(H):(quinone-acceptor) oxidoreductase
(EC 1.6.99.2)] (Tsuda et al., 1984), an enzyme that catalyses
the two-electron reduction of quinone compounds (Ernster,
1987). Total 4NQO reductase activity can be readily meas-
ured in crude cell-extract preparations (Sugimura et al., 1966;
Tsuda et al., 1984). 4HAQO is in turn esterified to acyl-
4HAQO, an ultimate carcinogen that reacts at the N2 and
the C8 positions of guanosine and at the N6 position of
adenosine (Tada & Tada, 1975; Galiegue-Zouitina et al.,
1985). In repair-competent human cells, 4NQO-induced
DNA lesions are operated on by both the nucleotide and
base modes of excision repair (Regan & Setlow, 1974;
Hanawalt et al., 1979).
To explore the basis of the unusual carcinogen-resistance
phenotype displayed by fibroblast strains from available
informative members of the cancer-prone family under study,
we have also compared these strains with normal controls
with respect to: (i) initial yield of DNA damage formed upon
exposure to a given concentration of 4NQO; (ii) capacity to
perform DNA repair following 4NQO treatment; and (iii)
kinetics of intracellular accumulation and rate of bioreduc-
tion of the compound.
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Figure 1 Abridged pedigree of a family with multiple polyposis and sarcomas.
Materials and methods
Cells and their cultivation
Pertinent characteristics of the fibroblast strains and their
human donors are given in Table I. The cells were cultured
at 37°C in Ham's F12 medium supplemented with 10% (v/v)
foetal bovine serum (Bockneck Laboratories Inc., Toronto,
ON), 1 mM glutamine and antibiotics (100 IU ml-' penicillin
G and 100 l.g ml-' streptomycin sulphate; GIBCO Labora-
tories, Grand Island, NY) in a humidified atmosphere of 5%
CO2 in air. Cultures were tested for Mycoplasma contamina-
tion and found to be negative by the [3H]uracil/[3H]uridine
uptake assay of Schneider et al. (1974). All strains were used
between passages 10 and 18 (1:3-split passage).
Radioactive labelling ofgenomic DNA
For alkaline sucrose sedimentation analysis, cellular DNA
was labelled by incubating exponentially growing cultures for
24 h in thymidine (dThd)-free medium containing 2.4 x 101"
Bq mmol-' [methyl-3H]dThd at 1.8 x l04 Bq ml-' or 2.0 x
I0O Bq mmol-' [methyl-14C]dThd at 3.7 x 104Bq ml-' (New
England Nuclear Canada, Lachine, PQ).
Radiation treatment protocols
Monolayer cultures were washed with prewarmed (37°C)
phosphate-buffered saline (PBS) and exposed to a bank of
15W (low-pressure mercury vapour) germicidal lamps (Model
GE 15T8; General Electric, Toronto, ON) emitting 97% of
Table I Pertinent properties of dermal fibroblast strains and their human donors
Donor
Strain Clinical Relation
designation description Agea Sex to proband Supplier"
GM38 normal 9 female IMR
GM43 normal 32 female IMR
GM321 normal 40 female IMR
GM730 normal 45 female IMR
GM3652 normal 24 male IMR
CRL1120 normal 83 male Meloy
1066T normal 42 female Meloy
1283T normal 17 female Meloy
1387T normal 66 male Meloy
1461T normal 43 male Meloy
3437T glioblastoma, 26 female sister Meloy
acute nonlymphatic
leukaemia
3701T endometrial 75 female paternal Meloy
carcinoma aunt
3702T normal 66 male paternal Meloy
uncle
3703T normal 60 female mother Meloy
3704T leiomyoma 52 female paternal Meloy
aunt
aAge (yr) at biopsy. bIMR, Institute for Medical Research (Camden, NJ); Meloy, Meloy
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their radiant energy at 254 nm wavelength (incidence fluence
rate, 1.27 W m-2).
Exposure to 'Co y radiation was performed under oxia
(i.e. in equilibrium with air), employing a Gamma-ray 150
Beam-port Irradiator (Atomic Energy of Canada Limited,
Ottawa, ON) at a dose-rate of -0.95 Gy minm-.
Chemical genotoxins and treatment conditions
Concentrated solutions of 4NQO and MNU (Sigma Chemi-
cal Co., St. Louis, MO) were prepared by dissolving the
powdered compounds in absolute ethanol. Chemical treat-
ment was administered by rinsing monolayer cultures with
PBS (37°C) followed by their incubation for 30 min (4NQO)
or 1 h (MNU) in serum-free medium containing appropriate
amounts of each stock preparation.
Cytotoxicity assay
Cell killing in response to carcinogen treatment was assessed
as the loss of colony-forming ability (CFA) using the feeder
layer technique detailed previously (Mirzayans et al., 1989a,
1992). In brief, late logarithmic cultures were plated at ap-
propriate densities into 100-mm dishes (102 to I04 per dish)
and exposed to UV or chemical agents as described above.
Alternatively, the cells were harvested by trypsinisation and
suspended in ice-cold growth medium, treated with y rays,
and then plated out at cloning densities into 100-mm dishes.
Gamma ray-inactivated (50 Gy) feeder cells of the same
strain were added to all dishes so as to achieve a total density
of 5 x 104/dish. Cultures were incubated, with weekly med-
ium changes, for 14-21 days, after which they were fixed and
stained with crystal violet, and the number of macroscopic
colonies of 100 or more cells was scored. Dose-response
survival curves were generated by plotting CFA (expressed as
a percentage of the sham-treated controls) on a logarithmic
scale as a function of carcinogen dose on a linear scale.
Quantification of4NQO-induced alkali-labile DNA lesions
Cells of a given strain were prelabelled with 3H-dThd and
mixed at a ratio of 1:5 with 4C-dThd-labelled reference
(GM38) cells. The combined cell suspension was plated in
60-mm dishes (-2 x 105 cells/dish), incubated overnight in
growth medium, and then treated for 30 min with various
concentrations (1-4fLM) of 4NQO. After removal of 4NQO,
the cells were rinsed twice in ice-cold PBS and lysed. The
incidence of alkali-labile lesions was determined by velocity
sedimentation of cellular DNA in alkaline sucrose gradients
(for details, see Mirzayans et al., 1988a).
Measurement ofunscheduled DNA synthesis induced by 4NQO
Cells in logarithmic growth phase were harvested, seeded on
sterile glass cover slips, which had been placed in 35-mm
dishes (105 cells per dish), and incubated overnight. After
treatment with 4NQO (2fM) for 30 min, the cells were
incubated in dThd-free medium supplemented with 1.8 x 105
Bgml-' [methyl-3H]dThd (stock specific activity, 3.0 x 1012
Bg mmol ') for 1 h. Cover slips were mounted on glass
microscope slides. Individual slides were then rinsed with
PBS and incubated for 10 min with fixing solution [methanol/
acetic acid (3:1)] diluted 1:1 with PBS, followed by incubation
with stock fixing solution for a further 10 min, before being
allowed to dry in air. Using standard procedures (Waters,
1984), the slides were dipped in liquified Kodak NTB-2
nuclear track emulsion, dried and exposed (4°C) for 10 days.
Finally, the slides were developed and after cell staining with
the Giemsa's solution, the number of silver grains above the
nuclei of non-S-phase cells was scored.
Measurement ofintracellular accumulation of4NQO
Late logarithmic cultures were seeded in 60-mm dishes (105
cells/dish) and incubated for - 12 h. The monolayer cultures
were then rinsed with PBS (37°C) and incubated at 37°C for
various times in serum-free medium containing different
concentrations (0.5-4gM) of [5-3H]4NQO (stock specific
activity, 9.9 x 101 Bq mmol-1; Midwest Research Institute,
Kansas City, MO). The cells were lysed and the amount of
radioactivity in the lysates was determined by scintillation
counting (for particulars, see Mirzayans et al., 1988b).
Measurement of4NQO-reductase activity
Levels of 4NQO-reductase activity in fibroblast strains were
measured by the standard cell-free assay system in which
NADH is used as the electron donor (Sugimura et al., 1966;
Tsuda et al., 1984), as detailed elsewhere (Mirzayans et al.,
1989b). In brief, cells were disrupted by sonication and
centrifuged, whereupon appropriate volumes (> 200ytL) of
each supernatant (so as to contain 0.5 mg total protein) were
added to a reaction mixture (3 ml) consisting of 60 mM
potassium phosphate buffer (pH 6.4) and 0.2 mM 4NQO. The
bioreduction reaction (conducted at room temperature) was
initiated by introducing 0.15 mM NADH into the reaction
mixture, and was monitored by taking A340 recordings at
5-min intervals. Accordingly, the rate of NADH oxidation,
as manifested by the time-dependent decrease in NADH
absorption at 340 nm, served as a measure of total 4NQO
reductase activity.
Results
Sensitivity to DNA-damaging agents
Table II compares colony-forming abilities of the various
fibroblast strains in response to four genotoxic agents. For
each agent, the survival levels for at least four different doses
were determined and the DIo (dose reducing colony survival
to 10%) values were estimated by least-squares linear regres-
sion analysis of the exponential region of the survival curves
(Weeks et al., 1991). All five strains from the family members
examined showed abnormal resistance to 4NQO. The DIO
values of these strains (0.82-1.95 lM) differed from the mean
values obtained from normal strains (0.45ILM) by 1.8-4.3
fold. By contrast, these 4NQO-resistant strains exhibited nor-
mal colony-forming ability in response to 'Co y rays and
MNU; strains 3437T and 3701T for affected family members
also responded normally to the lethal effects of UV radiation.
Induction ofDNA damage and its repair in 4NQO-treated cells
A class of DNA damage induced by 4NQO undergoes deg-
radation, yielding DNA chain breakage, after relatively short
periods (<1 h) of incubation of the injured DNA at alkaline
pH (Regan & Setlow, 1974; Mirzayans et al., 1985). Conse-
quently, the incidence of these immediate alkali-labile modifi-
cations has been taken as an index for accurate measurement
of variations in 4NQO genotoxic dosimetry among different
strains (Mirzayans & Waters, 1981; Edwards et al., 1987;
Mirzayans et al., 1988b; 1989a). These alkali-labile lesions
constitute - 20% of the total damage induced in cellular
DNA by 4NQO (Regan & Setlow, 1974; Waters et al., 1977;
Brown et al., 1979; Mirzayans & Waters, 1981). The remain-
ing 80% of the 4NQO-DNA adducts, which are alkali-stable,
are removed by a long-patch excision repair pathway in
normal human cells and are thus responsible for much of the
unscheduled DNA synthesis (UDS) elicited by this chemical
(Regan & Setlow, 1974; Waters et al., 1977; Brown et al.,
1979; Mirzayans & Waters, 1981). As shown in Table III,
upon exposure to a given concentration of 4NQO, both the
amounts of DNA alkali-labile sites induced initially and the
levels of UDS arising in the first 2 h after drug treatment
were lower in 4NQO-resistant than in normal fibroblasts.4NQO RESISTANCE IN CELLS FROM CANCER-PRONE SUBJECTS 841
Table II Colony-forming ability of human fibroblast strains in response to the
various genotoxic agentsa
Oxic y-rays
(Gy)
3.83 ± 0.21b
4.11 ± 0.76
4.30 ± 0.18
4.00 ± 0.15
3.59 ± 0.20
3.42 ± 0.10
4.22 ± 0.17
3.74 ± 0.33
3.67 ± 0.07
4.01 ± 0.49
3.88 ± 0.08
4.46 ± 0.31
3.77 ± 0.24
4.05 ± 0.29
4.25 ± 0.19
4.17 ± 0.26
Colony-forming
Far UV
(Jm2)
15.2±0.3
NAC
15.8 + 2.6
15.6 ± 0.7
16.6 ± 0.2
14.6 ± 0.9
14.7 ± 1.7
13.7 ± 1.1
12.5 ± 1.6
16.4 ± 1.0
ability in response to:
4NQO
(lMx 0.5 h)
0.54 ± 0.02
0.49 ± 0.06
0.59 + 0.03
0.33 ± 0.05
NA
0.48 ± 0.05
NA
NA
0.30 ± 0.03
NA
15.0 ± 0.4 0.45 ± 0.04
12.8 ± 1.5
12.8 ± 1.5
NA
NA
NA
1.95 ± 0.20 (R)d
1.80± 0.10 (R)
1.12± 0.16 (R)
0.82± 0.10 (R)
1.27±0.11 (R)
MNU
(mM x I h)
1.31± 0.11
1.29± 0.09
1.04+0.10
1.20± 0.19
NA
1.57 ± 0.22
1.44± 0.33
1.35 ± 0.05
1.27 ± 0.03
1.59 ± 0.14
1.31 ± 0.05
1.34 ± 0.03
1.40 ± 0.35
1.36 ± 0.06
1.27 ± 0.13
1.26 ± 0.27
aThe survival data presented here form part of an ongoing study involving a panel
of - 180 fibroblast strains derived from healthy volunteers and persons afflicted with
one of 39 genetic and familial conditions predisposing to cancer (for results of
parallel studies, see Paterson et al., 1984b, 1986, 1989). bMean ( s.e.) of the D1o
values obtained in three or more independent experiments. The cloning efficiency of
all strains ranged from 30 to 60%. cNot available. dAssignment of each indicated
strain to the resistant (R) class was determined by using the standard error of the
difference between D1O values [two-tailed t test of Tarone et al. (1983)] as the
statistical test and P< 0.05 as the criterion of significant resistance.
Rates ofintracellular accumulation of4NQO
To assess the capacity of fibroblast strains to accumulate the
drug, cultures were incubated with tritiated 4NQO for var-
ious times, whereupon they were lysed and the amounts of
radioactivity in the lysates determined. The outcome of a
typical time-course experiment conducted on GM38 and
3437T cells is shown in Figure 2 and the results of multiple
experiments in which cultures were incubated with the drug
(1 pM) for 20 min are averaged in Table III. The levels of
radioactive material in GM38 and 3437T cell lysates in-
creased initially in a time-dependent manner and reached a
plateau within - 10 min of incubation with the radiolabelled
compound (Figure 2). The levels of radioactivity in cell
lysates of all five 4NQO-resistant strains were significantly
lower than that found in lysates of normal fibroblasts (Figure
2; Table III). The dose dependency of 4NQO uptake and
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Figure 2 Time-course for the accumulation of radiolabelled
4NQO (1 rAM) in GM38 (0) and 3437T (0) fibroblasts. For
experimental details, see Materials and methods.
retention for GM38 and 3437T cells is presented in Figure 3.
It is evident that 3437T cells accumulated substantially lower
amounts of drug over a wide range of treatment concentra-
tions, indicating that the differences in drug accumulation
between the two strains is maintained even after supralethal
(e.g. 4pM) exposures.
4NQO-reductase activity in cell sonicates
Rates of NADH oxidation by sonicates of normal and
4NQO-resistant fibroblast strains are presented in Table III.
Oxidation of NADH, which parallels the conversion of
4NQO to 4HAQO under the reaction conditions used (Tsuda
et al., 1984), occurred at comparable rates in sonicates of
3703T, 3704T and normal strains (19-21 nmol NADH oxi-
dised/mg protein/min), whereas sonicates of 3437T, and
3701T and 3702T displayed deficient capacities to catalise
this reaction (8-12 nmol NADH oxidised/mg protein/min).
Discussion
This study demonstrated that skin fibroblast strains derived
from five members of a polyposis/sarcoma family (Figure 1;
Table I) exhibit abnormal resistance to reproductive inactiva-
tion by 4NQO (Table II), a partially UV-mimetic and radio-
mimetic carcinogen (Regan & Setlow, 1974; Hanawalt et al.,
1979; Smith & Paterson, 1980). This unusual cytotoxic res-
ponse for noncancerous cell types correlated with the intro-
duction of an abnormally low amount of genomic DNA
damage on exposure to a given concentration of 4NQO, as a
result of decreased accumulation of the chemical in resistant
compared to normal fibroblasts (Table III). In addition,
sonicates of cells from two family members who had devel-
oped malignancies [i.e. strains 3437T and 3701T (Table I)]
and a member in the cancer-prone lineage [strain 3702T
(Figure 1)] exhibited a reduced capacity to bioactivate 4NQO
to a proximate carcinogen (Table III). As shown in Table II,
the 4NQO-resistant cells were inactivated at normal rates by
254 nm UV light, 'Co radiation or the alkylating agent
MNU, signifying that the DNA damage processing machin-
ery, including the nucleotide and base modes of the excision-
repair process, functions normally in the drug-resistant cells.
Strain
GM38
GM43
GM321
GM730
GM3652
CRL1 120
1066T
1283T
1387T
1461T
'Normal Mean'
3437T
3701T
3702T
3703T
3704T842 R. MIRZAYANS et al.
Table III Relationship between 4NQO-induced DNA damage and repair and rates of 4NQO uptake and
bioreduction in fibroblast strains
Alkali-labile 3H-4NQO
sites UDS accumulation 4NQO-reductase
Strain (per 10i daltons)a,b (grainslnucleus)c (CPM x 10-2)b,d activityb,e
GM38 3.6 0.5 38 4 58 2 20.8 1.2
GM43 4.2 0.3 43 6 56 1 21.2 2.0
GM730 3.9±0.2 40±2 62±3 19.1 ± 1.2
1387T 3.9±0.6 35±4 52±2 18.8±2.0
'Normal Mean' 3.9 1.2 39± I 57 2 19.9 0.6
3437T 0.8 ± 0.1 (4.8)f 9 ± 2 (4.3) 25 ± 2 (2.2) 8.1 ± 3.4 (2.4)
3701T 1.1 0.1 (3.5) 9±1 (4.3) 25 1 (2.2) 8.8 2.5 (2.2)
3702T 1.5 0.3 (2.6) 11±2 (3.5) 32 2 (1.7) 11.9 2.0 (1.6)
3703T 3.0 +0.5 (1.3) 29+3 (1.3) 45 4 (12) 21.1 2.9 (0.9)
3704T 1.6 0.5 (2.4) 17±2 (3.2) 41 1 (1.4) 19.1 1.5 (1.0)
aSite incidence immediately after 30-min exposure to 2gM 4NQO. The amounts of damage detected after 1 or
4jLM 4NQO in cells from family members were relatively comparable to that seen after 2JAM (data not shown).
bMean ( ± s.e.) of 3 to 5 independent experiments. cMeasured in cultures that were exposed to 2JAM 4NQO for
30 min and allowed to repair in the presence of 3H-dThd for 2 h. The number of grains above > 50 nuclei were
scored for each slide (duplicate slides per strain). Results from two independent experiments are averaged for
GM38, GM730, 3437T and 3701T fibroblasts. The five remaining strains were assayed in a single experiment.
dRadioactivity in lysates of cultures incubated with 3H-4NQO (1 pM) for 20 min. eQuantified by the initial rate of
NADH oxidation (expressed as nmol NADH oxidised/mg protein/min). f'Normal Mean' divided by value
obtained for indicated strain.
300
200
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Figure 3 Accumulation of radiolabelled 4NQO in GM38 (0)
and 3437T (0) fibroblasts. Data represent the mean (± range) of
the values obtained for two experiments in which cell cultures
were incubated with a range of drug concentrations for 10 and
20 min.
We reported previously (Mirzayans et al., 1988b; Mirzayans
& Paterson, 1991) that fibroblasts derived from subjects with
the radiosensitive disorder ataxia-telangiectasia (A-T; comple-
mentation group A) are hypersensitive to killing by 4NQO
and contain increased amounts of 4NQO-reductase activity.
These same 4NQO-sensitive cells (e.g. strain AT3BI), how-
ever, were found to accumulate radiolabelled 4NQO at nor-
mal rates (Mirzayans et al., 1988b). In contrast to that
observed with A-T strains, we have demonstrated here that
the 4NQO-resistant strains 3703T and 3704T perform 4NQO
bioreduction normally but accumulate radiolabelled 4NQO
to a reduced extent (Table III). These results imply that the
rate of 4NQO retention in human fibroblasts is independent
of cellular capacity to convert the parent compound to
4HAQO. Further studies are required to identify the various
metabolic pathways and other factors that govern the
accumulation of 4NQO in human cells, one or more of which
may be aberrant in the 4NQO-resistant strains reported here.
In another earlier study (Marshall et al., 1991a), strains
3437T, 3701T and 3702T were found to be more resistant to
mitomycin C (MMC)-induced cell killing than two strains
from unrelated normal donors. One of these MMC-resistant
strains (3437T) showed normal colony-forming ability on
exposure to the cross-linking agent cis-dichlorodiammine
platinum II (Marshall et al., 1989), implying that the en-
hanced resistance of these cells to MMC, which is also a
cross-linking agent (Fujiwara, 1982), does not result from
unusually rapid processing of DNA cross links. It should be
noted that only those 4NQO-resistant strains harbouring
reduced 4NQO-reductase activity (i.e. strains 3437T, 3701T
and 3702T, but not 3703T or 3704T) also exhibited
significant resistance to MMC. This is reminiscent of the
results of Akamatsu and coworkers (1983) who reported that
cells from certain patients with familial polyposis coli con-
tained increased 4NQO-reductase activity and were hypersen-
sitive to the lethal effects of both 4NQO and MMC.
Together, these observations strongly implicate a common
enzyme, presumably DT-diaphorase (Tsuda et al., 1984), in
the bioreduction of the two procarcinogens. In accord with
this notion, the aerobic reduction of both 4NQO (Tsuda et
al., 1984) and MMC (Keyes et al., 1989; Marshall et al.,
1991b) has been demonstrated to be inhibited by dicumarol,
a potent (although not specific) inhibitor of DT-diaphorase
(Ernster, 1967).
In our earlier work the level of DT-diaphorase activity was
also determined for the five fibroblast strains in the poly-
posis/sarcoma family. Enzyme activities of 1820 and 6680
nmol mg protein/min were present in the two normal strains
(GM38 and GM3529), whereas the activities in all five strains
from the family members were found to be markedly lower
than normal, ranging from 400-800 nmol mg protein/min in
3702T, 3703T and 3704T, to negligible levels (- 30 nmol mg
protein/min) in 3437T and 3701T (Marshall et al., 1991a). In
this communication cell sonicates of these same strains were
shown to carry out 4NQO bioreduction at rates which are
either comparable to (i.e. in 3703T, 3704T) or 40-60% lower
than (i.e. in 3437T, 3701T, 3702T) the rates measured in cell
preparations of four normal strains (Table III). These strik-
ing quantitative differences in the residual levels of DT-
diaphorase vs 4NQO-reductase present in the same strains
lend support to the hypothesis that a significant component
of 4NQO-reductase activity residing in human cells is confer-
red by reductase(s) distinct from DT-diaphorase.
Dermal fibroblasts from patients with the cancer-prone
diseases familial polyposis coli (Akamatsu et al., 1983), A-T
(Mirzayans et al., 1988b; Mirzayans & Paterson, 1991) and
dysplastic nevus syndrome (Mirzayans et al., 1989b) typically
display hypersensitivity to the cytotoxic action of 4NQO and4NQO RESISTANCE IN CELLS FROM CANCER-PRONE SUBJECTS 843
this abnormal cellular response is accompanied by an
enhanced capacity to bioreduce 4NQO to an activated
derivative. Conversely, strains 3437T, 3701T and 3702T from
three members of the cancer-prone family studied here
exhibited decreased susceptibility to 4NQO (Table II) and
contained reduced 4NQO-reductase activity (Table III). Fac-
tors that govern the expression of DT-diaphorase and other
cellular reductases (Tsuda et al., 1984) remain largely un-
known. Their identification should not only establish a
molecular basis for bioreduction of 4NQO and related com-
pounds in human cells, but may also provide new insight into
the nature of the fundamental genetic defects underlying
various cancer-prone disorders. In addition, the discovery of
other cancer-associated diseases characterised by anomalies
in DT-diaphorase activity may lead to an improved under-
standing of the link between DT-diaphorase up-regulation
[e.g., as seen in subjects with familial polyposis coli
(Akamatsu et al., 1983)] and down-regulation [e.g., as seen in
the donors of 3437T and 3701T (Table III)] and the occur-
rence of specific cancers.
The observation that strain 3703T from a spousal control
of the polyposis/sarcoma family displays enhanced resistance
to 4NQO cytotoxicity (Table II) was unexpected. It should
also be noted that strain 3704T from a disease-free family
member in the cancer-prone lineage exhibits 4NQO-hyper-
resistance coupled with decreased 4NQO-reductase/DT-dia-
phorase activity (Tables II and III; Marshall et al., 1991a).
These findings, however, do not rule out the possibility that
the propensity to develop cancer among family members and
the impaired capacity of their cultured fibroblasts to bio-
reduce 4NQO are causally related, each a manifestation of
the same primary genetic defect segregating in the family. In
fact, this association between cellular reductase activity and
tumorigenesis has been reported by other groups in diverse
experimental systems (reviewed in Marshall et al., 1991a).
Moreover, an increasing body of evidence suggests that the
principal defect in A-T may reside in a regulatory gene whose
product may govern the expression of multiple homeostatic
mechanisms including those controlling the bioreduction of
4NQO and other xenobiotics (Mirzayans et al., 1989a).
Identification of the primary genetic defect underlying cancer
proneness in the family studied here may help to elucidate
the functional significance of these homeostatic mechanisms.
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